# BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

> **NCT00389402** · PHASE4 · COMPLETED · sponsor: **International Antiviral Therapy Evaluation Center** · enrollment: 120 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** saquinavir/ritonavir
- **DRUG:** atazanavir/ritonavir

## Key facts

- **NCT ID:** NCT00389402
- **Lead sponsor:** International Antiviral Therapy Evaluation Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389402, "BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00389402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*